Company / R&D per Share
Axsome Therapeutics, Inc. R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$3.77
FY2025
5-year range
$1.53 / $3.95
FY2021-FY2025
Trend
-4.7%
vs FY2024
Sector context
#56 of 208
Health Care
What the data says
At $3.77, Axsome Therapeutics, Inc.'s r&d per share ranks #56 of 208 in the Health Care sector. R&D per Share has fluctuated over the past 10 years, ranging from $0.87 in FY2018 to $3.95 in FY2024.
Based on SEC 10-K filings.
3.77 in FY2025 with a 5-year CAGR of +14.8%.
Improved from $2.25 to $3.77 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +35.0%
- 5-Year CAGR
- +14.8%
- 10-Year CAGR
- -
Sector benchmark
#56 of 208 in Health CareTop 27% of 208This company $3.77 Sector average $28.82
▼
-86.9% below sector average
Key checks
Key Insights
- In FY2025, r&d per share decreased 4.7% year-over-year.
- Ranks #56 out of 208 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2024.
- Lowest r&d per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -1.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.77 | -4.7% |
| FY2024 | $3.95 | +75.5% |
| FY2023 | $2.25 | +46.9% |
| FY2022 | $1.53 | -0.7% |
| FY2021 | $1.54 | -18.2% |
| FY2020 | $1.89 | +19.7% |
| FY2019 | $1.58 | +80.4% |
| FY2018 | $0.87 | -0.3% |
| FY2017 | $0.88 | -20.8% |
| FY2016 | $1.11 | +95.1% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026